A/HRC/29/44 Contents Paragraphs Page I. Introduction ............................................................................................................. 1–3 3 II. Opening of the Social Forum .................................................................................. 4–6 3 III. Summary of proceedings ......................................................................................... 7–58 4 A. Keynote speakers and general statements ....................................................... 7–10 4 B. Overview of access to medicines in the context of the right to health ............ 11–15 5 C. Improving health delivery systems in challenging contexts ........................... 16–20 6 D. Access to medicines for women and children ................................................. 21–25 8 E. Intellectual property rights and access to medicines ....................................... 26–30 9 F. Lessons learned and emerging challenges in the global response to AIDS .... 31–35 10 G. Patient-centred approaches to access to medicines ......................................... 36–41 11 H. Breakout discussion groups and plenary discussion ....................................... 42–43 13 I. Innovative approaches to promoting access to medicines .............................. 44–49 13 J. Good practices in promoting access to medicines (round table) ..................... 50–58 15 Conclusions and recommendations ......................................................................... 59–74 18 A. Conclusions .................................................................................................... 60–66 18 B. Recommendations........................................................................................... 67–74 19 I. Provisional agenda ........................................................................................................................... 21 II. List of participants............................................................................................................................ 22 IV. Annexes 2